IMARC Group’s latest report, titled “Fetal Bovine Serum Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global fetal bovine serum market size reached US$ 948.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,333.3 Million by 2028, exhibiting a growth rate (CAGR) of 5.75% during 2023-2028.
Fetal bovine serum (FBS) is a significant component of animal cell culture media that is generally acquired from bovine fetuses of cows. It is the liquid fraction of clotted blood from fetal calves, fibrin, and depleted cells that contain a high amount of macromolecular and nutritional factors essential for cell growth. Additionally, it also includes sugars, hormones, low gamma globulin content, amino acids, and hormones and is extensively used in a variety of applications, such as human and animal vaccine production, proliferation in eukaryotic cell culture, cancer research and development of biopharmaceuticals. Some of the products utilized under fetal bovine serum include chromatographic, exosome-depleted, charcoal-stripped, dialyzed fetal bovine serum, and stem cells.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/fetal-bovine-serum-market/requestsample
Competitive Landscape with Key Players:
The competitive landscape of the industry has also been examined along with the profiles of the key players being
- Atlas Biologicals Inc
- Biological Industries (Sartorius AG)
- Bio-Techne Corporation
- BioWest, Bovogen Biologicals Pty Ltd
- General Electric Company
- HiMedia Laboratories
- Merck KGaA
- PAN-Biotech
- Rocky Mountain Biologicals
- TCS Biosciences Ltd
- Thermo Fisher Scientific Inc
Fetal Bovine Serum Market Trends:
The escalating number of research and development (R&D) activities majorly drives the global market. This can be attributed to the rising funding by governing and private agencies to develop novel and effective biopharmaceutical drugs. Along with this, the widespread adoption of fetal bovine serum (FBS) in generating stem cells to treat patients suffering from chronic and acute lung damage is also significantly supporting the market. In addition to this, its vital role in numerous scientific research facilities for the purpose of keeping cells alive for growing, evolving, and dividing due to the presence of several growth factors and antibodies is considered as a growth-inducing factor. Moreover, continual technological advancements in the field of biotechnology are creating a positive market outlook.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/fetal-bovine-serum-market
Key Market Segmentation:
Breakup by Product:
- Charcoal Stripped
- Chromatographic
- Dialyzed Fetal Bovine Serum
- Exosome Depleted
- Stem Cell
- Others
Breakup by Application:
- Biopharmaceuticals
- Cell Culture
- Human and Animal Vaccine Production
- Others
Breakup by End User:
- Biotechnology and Pharmaceutical Companies
- Academic Institutes
- Research Laboratories
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800